Riopan Plus Double Strength Drug Interactions
Currently displaying 125 drugs known to have a moderate interaction with Riopan Plus Double Strength (magaldrate / simethicone).
Moderate interactions with Riopan Plus Double Strength (magaldrate / simethicone)
Note: Showing generic names only.
A
- acalabrutinib
- acetohexamide
- alendronate
- allopurinol
- amphetamine
- amprenavir
- aspirin
- atazanavir
- atropine
- azithromycin
B
C
- calcifediol
- calcitriol
- carbonyl iron
- cefdinir
- cefditoren
- cefpodoxime
- cefuroxime
- ceritinib
- chenodeoxycholic acid
- chloroquine
- chlorpropamide
- cholecalciferol
- choline salicylate
- cinoxacin
- ciprofloxacin
D
- dabigatran
- dabrafenib
- dasatinib
- deferasirox
- deferiprone
- delafloxacin
- delavirdine
- demeclocycline
- dextroamphetamine
- dihydrotachysterol
- doxercalciferol
- doxycycline
E
F
G
H
I
K
L
- levofloxacin
- levoketoconazole
- levothyroxine
- levothyroxine / liothyronine
- liothyronine
- liotrix
- lisdexamfetamine
- lomefloxacin
M
- magnesium salicylate
- methamphetamine
- methenamine
- minocycline
- misoprostol
- moxifloxacin
- multivitamin with iron
- multivitamin with iron and fluoride
- multivitamin, prenatal
- mycophenolate mofetil
- mycophenolic acid
N
O
P
- pancreatin
- pancrelipase
- paricalcitol
- pazopanib
- penicillamine
- peppermint oil
- pexidartinib
- phenytoin
- proguanil
- propantheline
- pyrimethamine
Q
R
S
T
Riopan Plus Double Strength disease interactions
There are 3 disease interactions with Riopan Plus Double Strength (magaldrate / simethicone) which include:
More about Riopan Plus Double Strength (magaldrate / simethicone)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: antacids
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.